Global Neuromodulation Market Share Likely to Grow At a CAGR of 9% By 2028 - Says Facts & Factors

Findings from Facts and Factors report "Neuromodulation Market By Technology (Internal Neuromodulation and External Neuromodulation), By Application (Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Urinary, and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Obsessive-Compulsive Disorder, Migraine, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020-2026" states that the global Neuromodulation market in 2019 was approximately USD 5.5 Billion. The market is expected to grow at a CAGR of 9% and is anticipated to reach around USD 9.5Billion by 2026.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.fnfresearch.com/global-neuromodulation-market-by-technology-internal-neuromodulation-and-798

Neurological disorders such as Alzheimer's disease, epilepsy, and Parkinson's disease generally affect the central and peripheral nervous systems. There are certain neurological disorders that are caused by bacterial, viral, and fungal infections as well. Thus, there is an urgent need for neuromodulator technologies to manage such disorders by using small electrodes&pulse generators to produce electrical stimulations to supplement neurological activities in subjects.

Market Drivers:

The key drivers of the global Neuromodulation market are the growing prevalence of neurological disorders and the increasing ongoing research or R&D activities for increasing the application of neuromodulators. Additionally, the growing awareness among people regarding neurodegenerative disorders helps increase the demand for neuromodulator technologies across the globe.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.fnfresearch.com/sample/global-neuromodulation-market-by-technology-internal-neuromodulation-and-798

However, the expense of neuromodulator procedures and equipment, the stringent approval policies, and the demand for the expert workforce are likely to hinder the global Neuromodulation market growth. The growing geriatric population across the globe increases the number of neurological disorders such as Alzheimer's and Parkinson's diseases and the surging awareness regarding the safety and efficacy of neurostimulator devices will further supplement the market growth.

Market Segment Dominance:

Spinal cord stimulation is expected to dominate the technology segment
Spinal cord stimulation has gained a lot of momentum over the years owing to the increasing incidences of chronic back pain among people across the globe. This technology is being extensively used to treat peripheral vascular disease, failed back surgery syndrome, refractory angina pectoris, and complex regional pain syndrome.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭@https://www.fnfresearch.com/inquiry/global-neuromodulation-market-by-technology-internal-neuromodulation-and-798

Parkinson's disease held the majority of the market share of the application segment
Parkinson's disease is expected to hold the majority of the market share owing to the rising incidences of the disease worldwide. In addition, the growing R&D activities in Parkinson's disease help propel market growth. The increasing government and private programs to surge awareness concerning mental health and the prevalence of neurological disorders are expected to fuel the growth of the global Neuromodulation market.

Market Players:

Some of the key market players of the global Neuromodulation market include Boston Scientific Corporation, Medtronic, Abbott, Synapse Biomedical, Inc., LivaNova, Nevro Corporation, NeuroPace, NeuroSigma, Neuronetics, and BioControl Medical.

𝐍𝐞𝐞𝐝 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.fnfresearch.com/customization/global-neuromodulation-market-by-technology-internal-neuromodulation-and-798

This report segments the global Neuromodulation market as follows:

Global Neuromodulation Market: Technology Segmentation Analysis

Internal Neuromodulation
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Gastric Electrical Stimulation
External Neuromodulation
Transcutaneous Electrical Nerve Stimulation (TENS)
Transcranial Magnetic Stimulation (TMS)
Respiratory Electrical Stimulation (RES)

Global Neuromodulation Market: ApplicationSegmentation Analysis

Chronic Pain Management
Failed Back Syndrome
Epilepsy
Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson's Disease
Obsessive-Compulsive Disorder
Migraine
Others

𝐑𝐞𝐚𝐝 𝐛𝐮𝐲𝐧𝐨𝐰 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧@https://www.fnfresearch.com/buynow/su/global-neuromodulation-market-by-technology-internal-neuromodulation-and-798

Global Neuromodulation Market: Regional Segmentation Analysis

North America
The U.S.
Canada
Europe
Germany
The UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa

Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client's/customer's conviction in our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

This release was published on openPR.